| Literature DB >> 29573500 |
N Bradley1, M Lloyd-Williams1, C Dowrick1.
Abstract
Individuals managing the challenges of life-limiting illness require adequate social support to maintain quality of life. Qualitative research reports that patients value highly the social support obtained in palliative care interventions such as day care and group therapies. This systematic review aims to summarise existing quantitative evidence on palliative care interventions that facilitate social support. Research literature was systematically searched using electronic databases and key journals. Searches returned a total of 6,247 unique titles of which sixteen were eligible for inclusion. Interventions include group therapies, group practical interventions and palliative day care. Outcome measures and study designs were heterogeneous. Only one study used a validated outcome measure of social support. Benefits were influenced by participant characteristics such as baseline distress. Partial economic evaluation was attempted by two studies. Methodological challenges include attrition and use of outcome measures that were insensitive to change. Statistically significant results were reported in psychological and physical domains. Evidence is limited due to methodological issues and a scarcity of quantitative research, particularly regarding long-term benefits and cost-effectiveness. Interventions may be more beneficial to some groups than others. 2018 The Authors. European Journal of Cancer Care Published by John Wiley & Sons Ltd.Entities:
Keywords: Social support; day care; group interventions; palliative care; psychosocial care; systematic review
Mesh:
Year: 2018 PMID: 29573500 PMCID: PMC6001732 DOI: 10.1111/ecc.12837
Source DB: PubMed Journal: Eur J Cancer Care (Engl) ISSN: 0961-5423 Impact factor: 2.520
Figure 1Article selection process for this review. From Moher et al. (2009)
Details of included studies (n = 16)
| Study | Quality | Country | Method | Intervention | Population | Study period (attrition) | QOL outcomes | Other outcomes | Subsequent reports |
|---|---|---|---|---|---|---|---|---|---|
| Clark et al. ( | 31 | USA | Randomised controlled trial | Multidisciplinary group intervention |
Advanced cancer outpatients | 27 weeks (14.7%) |
FACT‐G. |
FACT‐SWB, POMS, caregiver QOL |
Gender differences in response at week 4 (Lapid et al., |
| Classen et al. ( | 30 | USA | Randomised prospective study | Supportive‐expressive group therapy |
Advanced breast cancer outpatients | 1 year (18.4%) | N/A |
POMS, IES |
Intervention reduced pain experience ( |
| Edelman, Bell, and Kidman ( | 30 | Australia | Randomised prospective study | Group cognitive behaviour therapy |
Advanced breast cancer outpatients | 6 months (31.5%) | N/A |
POMS, Coppersmith self‐esteem inventory | No survival difference after 5 years, 70.2% mortality (Edelman, Lemon, Bell, & Kidman, |
| Edmonds et al. ( | 31 | Canada | Randomised prospective study | Long‐term therapeutic support group |
Advanced breast cancer outpatients | 14 months (42.4%) |
FLIC. |
DUFSS, POMS‐SF, MAC, rationality/defensiveness, social desirability | No survival difference after 5 years ( |
| P. J. Goodwin et al. ( | 32 | Canada | Randomised prospective study | Supportive‐expressive group therapy |
Advanced breast cancer outpatients | 1 year (37.4%) |
EORTC QLQ‐C3O. |
POMS, pain and suffering scale |
Cost‐minimisation analysis using resource use and patient outcomes, no significant result (Lemieux et al., |
| D. Goodwin et al. ( | 29 | UK | Non‐randomised prospective comparative study | Palliative day care |
New referrals to five day care centres (mixed diagnoses—96% cancer) | 12–15 weeks (57%) |
MQOL. |
POS. | Cost‐effectiveness study using resource use, limited evidence available, inconclusive result (Douglas et al., |
| Higginson et al. ( | 31 | UK | Quasi‐experimental prospective comparative study | Palliative day care |
New referrals to palliative care (mixed diagnoses—87% cancer) | 12–15 weeks (55.3%) |
EQ‐5D VAS. |
HHI, POS, healthcare usage. | Increases to hope lost by 12–15 weeks ( |
| Kilonzo et al. ( | 25 | Ireland | Reports on implementation of PROMs (no control) | Palliative day care |
Attendees of day care centre (mixed diagnoses—68% cancer) | 8 weeks (66.7%) |
MQOL. |
ESAS, EFAT, PCPSS. | N/A |
| Kissane et al. ( | 28 | Australia | Randomised prospective study | Supportive‐expressive group therapy |
Advanced breast cancer outpatients | 2 years (47.4%) |
EORTC QLQ‐C30. |
MILP, IES, M‐MAC. | Qualitative report on the experience of SEGT (Kissane et al., |
| Leppert et al. ( | 31 | Poland | Prospective comparative study across three settings (day care, home care and inpatient unit) | Palliative day care |
All advanced cancer patients | 7 days (14%) |
EORTC QLQ‐C15‐PAL. |
ESAS, KPS. | N/A |
| D. K. Miller et al. ( | 33 | USA | Randomised prospective study | Supportive‐affective group therapy |
Outpatients with mixed diagnoses | 1 year (26.1%) | N/A |
BDI, SSAI, spiritual well‐being, death distress. | N/A |
| Roulston et al. ( | 31 | UK (NI) | Pilot study of intervention (no control) | Condition‐specific multidisciplinary group intervention |
Advanced lung cancer outpatients | 4 weeks (0) |
EQ‐5D. |
ECOG, EQ‐VAS, HADS. | N/A |
| Rummans et al. ( | 31 | USA | Randomised controlled trial | Multidisciplinary group intervention |
Advanced cancer outpatients | 27 weeks (20.4%) |
LASAs. |
POMS‐SF, FACT‐SWB, SDS. |
Intervention effective at all time points for participants over 65 years (Lapid et al., |
| Spiegel et al. ( | 26 | USA | Randomised prospective study | Long‐term therapeutic support group |
Advanced breast cancer outpatients | 1 year (48.3%) | N/A |
POMS, HLC, maladaptive coping. |
Survival difference after 10 years ( |
| Sviden et al. ( | 26 | Sweden | Prospective study with matched comparison group | Palliative day care |
Advanced cancer outpatients | 5 weeks (27.1%) |
EORTC QLQ‐30. |
Mood adjective list. | N/A |
| Tsianakas et al. ( | 29 | UK | Randomised controlled trial | Group walking intervention |
Advanced cancer outpatients |
24 weeks |
FACT‐G. |
Physical activity, fatigue, stress, anxiety, depression. | N/A |
DUFSS, Duke‐UNC Functional Social Support Questionnaire; EFAT, Edmonton Functional Assessment Tool; EORTC QLQ‐C15‐PAL, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire—Core 15 Palliative Care; EORTC QLQ‐C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire—Core 30; EQ‐5D, EuroQol 5 Dimensions Questionnaire; EQ‐VAS, EuroQol Visual Analogue Scale; ESAS, Edmonton Symptom Assessment System; FACT‐G, Functional Assessment of Chronic Illness Therapy—General; FACT‐SWB, Functional Assessment of Chronic Illness Therapy—Spiritual Well‐being; FLIC, Functional Living Index for Cancer; HADS, Hospital Anxiety and Depression Scale; HHI, Herth Hope Index; HLC, Health Locus of Control; IES, Impact of Event Scale; KPS, Karnofsky Performance Status; LASAs, Linear Analog Scales of Assessment for QOL; MAC, Mental Adjustment to Cancer Scale; MILP, Monash Interview for Liaison Psychiatry; M‐MAC, Mini‐Mental Adjustment to Cancer Scale; MQOL, McGill Quality of Life Questionnaire; PCPSS, Palliative Care Problem Severity Scale; POMS, Profile of Mood States POMS‐SF, Profile of Mood States‐short form; POS, Palliative Outcome Scale; QOL, Quality of Life; SDS, Symptom Distress Scale; SSAI, Spielberger State Anxiety Inventory.